Advocacy in Action: September 26

September 26, 2023

What's happened

September 1, Roundtable on Improving Canada’s Medical Countermeasure Readiness for Health Emergencies 

CPO Rita Dhami participated in a roundtable with Deputy Minister Stephen Lucas and spoke on how to improve Canada's medical countermeasure preparedness for future health emergencies. Rita covered hospital pandemic preparedness plans including interdepartmental key accountabilities and critical paths. Additionally, she stressed the importance of coordination among all healthcare providers across Canada, as well as the importance of public communication and education. 

September 12, Appropriate Use Advisory Committee Interim Report Roundtable 

A unified appropriate-use program is being developed by the Canadian Drug Agency (CDA) to improve the pharmaceutical landscape. During this interim report roundtable, Rita spoke about the importance of promoting evidence-based approaches and interventions to improve the pharmaceutical industry. In addition to identifying drivers of inappropriate use, hospital pharmacy teams also employ multi-pronged behaviour change strategies in order to improve prescribing. 

September 14, European Association of Hospital Pharmacists meeting 

Canadian Society of Hospital Pharmacists (CSHP) President Sean Spina, CEO Jody Ciufo, and CPO Rita Dhami met with Ambassadors from the European Association of Hospital Pharmacists (EAHP) where EAHP introduced their organization and its strategic priorities. Over the course of this meeting, both organizations found several areas of overlap in their work including a shared focus on vision for practice, drug shortages, sustainability, and human resource challenges. It is expected that this meeting will be the first of many collaborations between CSHP and EAHP.

Ongoing, Health Canada Drug Shortages meetings

CSHP is providing weekly feedback and amplifying the voice of hospital pharmacy on drug shortages.

  • Sept. 15: Multi-Stakeholder Call #2 – Supply disruptions of Ozempic 
  • Sept. 20: Multi-Stakeholder Call #12 – Shortages of Amoxicillin Oral Suspension/Capsules/Tablets

What's happening 

September 25, Canadian Nosocomial Infection Surveillance Program

CSHP will be attending a meeting regarding the Canadian Nosocomial Infection Surveillance program, a collaboration between the Public Health Agency of Canada (PHAC) and the National Microbiology Laboratory (NML), which will be addressing the program’s Antimicrobial Medication Use data in hospitals. The meeting will also highlight protocols and current advocacy to bring new antimicrobials to Canada. As advocates for antimicrobial stewardship, CSHP looks forward to being updated on these topics and their impact on hospital pharmacy.  

What's worth repeating

August 30, Drug Shortages Consultation has been submitted

CSHP’s submission provided four fundamental pillars that serve as a blueprint for collaborative action between Health Canada and fellow stakeholders. View the submission here.

To catch up on CSHP advocacy news, click here.

Have a question about Advocacy in Action or CSHP's advocacy and consultation work?
Reach out to our professional practice team!